Cosmos Health (COSM) Cash & Equivalents (2011 - 2026)

Cosmos Health (COSM) has 16 years of Cash & Equivalents data on file, last reported at $514702.0 in Q1 2026.

• Quarterly Cash & Equivalents fell 30.72% year-over-year to $514702.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $514702.0 (down 30.72% YoY) and the FY2025 annual result came in at $715674.0, up 4649.94% from the prior year.
• Cash & Equivalents retreated to $514702.0 in Q1 2026, from $715674.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $20.7 million in Q4 2022 to a low of $15067.0 in Q4 2024.
• A 5-year average of $3.0 million and a median of $865099.0 in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 7142.8% — and 2024, when it tumbled 99.61%.
• Tracing COSM's Cash & Equivalents over 5 years: stood at $20.7 million in 2022, then tumbled by 81.53% to $3.8 million in 2023, then plunged by 99.61% to $15067.0 in 2024, then jumped by 4649.94% to $715674.0 in 2025, then slipped by 28.08% to $514702.0 in 2026.
• The last three Cash & Equivalents figures came in at $514702.0 (Q1 2026), $715674.0 (Q4 2025), and $889441.0 (Q3 2025), per Business Quant data.